Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
about
Reporting characteristics of cancer pain: a systematic review and quantitative analysis of research publications in palliative care journals.The application of genomic and molecular data in the treatment of chronic cancer pain.Ibandronate: The loading dose concept in the treatment of metastatic bone pain.Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer.Pain outcomes in patients with advanced breast cancer and bone metastases
P2860
Bone pain reduction in patients with metastatic breast cancer treated with ibandronate-results from a post-marketing surveillance study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Bone pain reduction in patient ...... -marketing surveillance study.
@en
Bone pain reduction in patient ...... -marketing surveillance study.
@nl
type
label
Bone pain reduction in patient ...... -marketing surveillance study.
@en
Bone pain reduction in patient ...... -marketing surveillance study.
@nl
prefLabel
Bone pain reduction in patient ...... -marketing surveillance study.
@en
Bone pain reduction in patient ...... -marketing surveillance study.
@nl
P2093
P1476
Bone pain reduction in patient ...... t-marketing surveillance study
@en
P2093
Andreas H A Kurth
Andreas Sandermann
Hans-Bernd Sittig
Harald Meden
Ingo J Diel
Michael Maasberg
P2888
P304
P356
10.1007/S00520-009-0749-5
P577
2010-02-12T00:00:00Z